Wan Yan Huan - Net Worth and Insider Trading
Wan Yan Huan Net Worth
The estimated net worth of Wan Yan Huan is at least $38,318 dollars as of 2024-06-22. Wan Yan Huan is the senior management of Jiangsu Kanion Pharmaceutical Co Ltd and owns about 2,380 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) stock worth over $38,318. Details can be seen in Wan Yan Huan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wan Yan Huan has not made any transactions after 2017-02-07 and currently still holds the listed stock(s).
Transaction Summary of Wan Yan Huan
Wan Yan Huan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wan Yan Huan owns 1 companies in total, including Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) .
Click here to see the complete history of Wan Yan Huan’s form 4 insider trades.
Insider Ownership Summary of Wan Yan Huan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600557 | Jiangsu Kanion Pharmaceutical Co Ltd | 2017-02-07 | senior management |
Wan Yan Huan Latest Holdings Summary
Wan Yan Huan currently owns a total of 1 stock. Wan Yan Huan owns 2,380 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) as of February 7, 2017, with a value of $38,318.
Latest Holdings of Wan Yan Huan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600557 | Jiangsu Kanion Pharmaceutical Co Ltd | 2017-02-07 | 2,380 | 16.10 | 38,318 |
Holding Weightings of Wan Yan Huan
Wan Yan Huan Form 4 Trading Tracker
According to the SEC Form 4 filings, Wan Yan Huan has made a total of 0 transactions in Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) over the past 5 years. The most-recent trade in Jiangsu Kanion Pharmaceutical Co Ltd is the acquisition of 300 shares on February 7, 2017, which cost Wan Yan Huan around $5,154.
Insider Trading History of Wan Yan Huan
- 1
Wan Yan Huan Trading Performance
GuruFocus tracks the stock performance after each of Wan Yan Huan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wan Yan Huan is -6.5%. GuruFocus also compares Wan Yan Huan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wan Yan Huan within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wan Yan Huan's insider trading performs compared to the benchmark.
Performance of Wan Yan Huan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.43 | | | | | |
| Relative Return to S&P 500(%) | 0.99 | | | | | |
Wan Yan Huan Ownership Network
Wan Yan Huan Owned Company Details
What does Jiangsu Kanion Pharmaceutical Co Ltd do?
Who are the key executives at Jiangsu Kanion Pharmaceutical Co Ltd?
Wan Yan Huan is the senior management of Jiangsu Kanion Pharmaceutical Co Ltd.
Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jiangsu Kanion Pharmaceutical Co Ltd Insider Transactions
Wan Yan Huan Mailing Address
Above is the net worth, insider trading, and ownership report for Wan Yan Huan. Currently GuruFocus does not have mailing address information for Wan Yan Huan.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
